{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:02Z","timestamp":1787003642522,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Patients on peritoneal dialysis (PD) have an increased risk of cardiovascular disease (CVD) and an atherogenic lipid profile generated by exposure to high glucose dialysis solutions. In the general population, the reduction of classic lipids biomarkers is associated with improved clinical outcomes; however, the same results have not been seen in PD population, a lack of data this study aims to fulfill. Single-center prospective observational study of a cohort of CKD patients who started renal replacement therapy with continuous ambulatory peritoneal dialysis. The differences in the lipid profile and analytical variables before and 6\u00a0months after the start of peritoneal dialysis were analyzed. Samples were analyzed on an Ultra-Performance Liquid Chromatography system. Thirty-nine patients were enrolled in this study. Their mean age was 57.9\u2009\u00b1\u200916.3\u00a0years. A total of 157 endogenous lipid species of 11 lipid subclasses were identified. There were significant increases in total free fatty acids (p\u2009&lt;\u20090.05), diacylglycerides (p\u2009&lt;\u20090.01), triacylglycerides, (p\u2009&lt;\u20090.01), phosphatidylcholines (p\u2009&lt;\u20090.01), phosphatidylethanolamines (p\u2009&lt;\u20090.01), ceramides (p\u2009&lt;\u20090.01), sphingomyelins (p\u2009&lt;\u20090.01), and cholesterol esters (p\u2009&lt;\u20090.01) from baseline to 6\u00a0months. However, there were no differences in the classical lipid markers, neither lysophosphatidylcholines, monoacylglycerides, and sphingosine levels. 6\u00a0months after the start of the technique, PD patients present changes in the lipidomic profile beyond the classic markers of dyslipidemia.<\/jats:p>","DOI":"10.1038\/s41598-022-20757-9","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T09:09:52Z","timestamp":1664528992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Lipidic profiles of patients starting peritoneal dialysis suggest an increased cardiovascular risk beyond classical dyslipidemia biomarkers"],"prefix":"10.1038","volume":"12","author":[{"given":"Julia Hern\u00e1ndez","family":"Lluesa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Carlos","family":"L\u00f3pez-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Jes\u00fas Broseta","family":"Monz\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Roca","family":"Marug\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris Viejo","family":"Boyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Rodr\u00edguez-Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aina","family":"G\u00f3mez-Bori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amparo Soldevila","family":"Orient","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n Devesa","family":"Such","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar S\u00e1nchez","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio Hern\u00e1ndez","family":"Jaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"issue":"19","key":"20757_CR1","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1056\/NEJMra1104901","volume":"365","author":"O Quehenberger","year":"2011","unstructured":"Quehenberger, O. & Dennis, E. A. The human plasma lipidome. N. Engl. J. Med. 365(19), 1812\u20131823 (2011).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"20757_CR2","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.bbamem.2013.11.010","volume":"1838","author":"GL Nicolson","year":"2014","unstructured":"Nicolson, G. L. & Ash, M. E. Lipid replacement therapy: A natural medicine approach to replacing damaged lipids in cellular membranes and organelles and restoring function. Biochim. Biophys. Acta 1838(6), 1657\u20131679. https:\/\/doi.org\/10.1016\/j.bbamem.2013.11.010 (2014) (Epub 2013 Nov 21).","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"20757_CR3","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","volume":"42","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak, M. J. et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 42(5), 1050\u20131065. https:\/\/doi.org\/10.1161\/01.HYP.0000102971.85504.7c (2003).","journal-title":"Hypertension"},{"issue":"1","key":"20757_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","volume":"116","author":"EL Schiffrin","year":"2007","unstructured":"Schiffrin, E. L., Lipman, M. L. & Mann, J. F. Chronic kidney disease: Effects on the cardiovascular system. Circulation 116(1), 85\u201397. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.678342 (2007).","journal-title":"Circulation"},{"issue":"2","key":"20757_CR5","doi-asserted-by":"publisher","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","volume":"290","author":"ND Vaziri","year":"2006","unstructured":"Vaziri, N. D. Dyslipidemia of chronic renal failure: The nature, mechanisms, and potential consequences. Am. J. Physiol. Renal. Physiol. 290(2), F262\u2013F272. https:\/\/doi.org\/10.1152\/ajprenal.00099.2005 (2006).","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"1\u20133","key":"20757_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000321845","volume":"31","author":"ND Vaziri","year":"2011","unstructured":"Vaziri, N. D. & Norris, K. Lipid disorders and their relevance to outcomes in chronic kidney disease. Blood Purif. 31(1\u20133), 189\u2013196. https:\/\/doi.org\/10.1159\/000321845 (2011) (Epub 2011 Jan 10).","journal-title":"Blood Purif."},{"issue":"10","key":"20757_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/IJNRD.S101808","volume":"7","author":"I Mikolasevic","year":"2017","unstructured":"Mikolasevic, I., \u017dutelija, M., Mavrinac, V. & Orlic, L. Dyslipidemia in patients with chronic kidney disease: Etiology and management. Int. J. Nephrol. Renovasc. Dis. 7(10), 35\u201345. https:\/\/doi.org\/10.2147\/IJNRD.S101808 (2017).","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"issue":"7","key":"20757_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3747\/pdi.2014.00008","volume":"35","author":"Q Guo","year":"2015","unstructured":"Guo, Q. et al. The effect of fluid overload on clinical outcome in Southern Chinese patients undergoing continuous ambulatory peritoneal dialysis. Perit. Dial. Int. 35(7), 691\u2013702. https:\/\/doi.org\/10.3747\/pdi.2014.00008 (2015) (Epub 2015 Jul 7).","journal-title":"Perit. Dial. Int."},{"issue":"3","key":"20757_CR9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/ckj\/sfw007","volume":"9","author":"A Rinc\u00f3n Bello","year":"2016","unstructured":"Rinc\u00f3n Bello, A. et al. Fat tissue and inflammation in patients undergoing peritoneal dialysis. Clin. Kidney J. 9(3), 374\u2013380. https:\/\/doi.org\/10.1093\/ckj\/sfw007 (2016) (Epub 2016 Mar 24).","journal-title":"Clin. Kidney J."},{"issue":"14","key":"20757_CR10","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa050461","volume":"352","author":"JC LaRosa","year":"2005","unstructured":"LaRosa, J. C. et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N. Engl. J. Med. 352(14), 1425\u20131435. https:\/\/doi.org\/10.1056\/NEJMoa050461 (2005) (Epub 2005 Mar 8).","journal-title":"N. Engl. J. Med."},{"issue":"9784","key":"20757_CR11","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","volume":"377","author":"C Baigent","year":"2011","unstructured":"Baigent, C. et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial. Lancet 377(9784), 2181\u20132192. https:\/\/doi.org\/10.1016\/S0140-6736(11)60739-3 (2011) (Epub 2011 Jun 12).","journal-title":"Lancet"},{"issue":"6","key":"20757_CR12","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1194\/jlr.R300004-JLR200","volume":"44","author":"X Han","year":"2003","unstructured":"Han, X. & Gross, R. W. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: A bridge to lipidomics. J. Lipid Res. 44(6), 1071\u20131079. https:\/\/doi.org\/10.1194\/jlr.R300004-JLR200 (2003) (Epub 2003 Apr 1).","journal-title":"J. Lipid Res."},{"issue":"1","key":"20757_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1194\/jlr.P055640","volume":"56","author":"R Loomba","year":"2015","unstructured":"Loomba, R., Quehenberger, O., Armando, A. & Dennis, E. A. Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis. J. Lipid Res. 56(1), 185\u2013192. https:\/\/doi.org\/10.1194\/jlr.P055640 (2015) (Epub 2014 Nov 17).","journal-title":"J. Lipid Res."},{"issue":"1","key":"20757_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2013.05.052","volume":"154","author":"VC Tam","year":"2013","unstructured":"Tam, V. C. et al. Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation. Cell 154(1), 213\u2013227. https:\/\/doi.org\/10.1016\/j.cell.2013.05.052 (2013).","journal-title":"Cell"},{"issue":"10","key":"20757_CR15","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nn.3195","volume":"15","author":"J Ji","year":"2012","unstructured":"Ji, J. et al. Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury. Nat. Neurosci. 15(10), 1407\u20131413. https:\/\/doi.org\/10.1038\/nn.3195 (2012) (Epub 2012 Aug 26).","journal-title":"Nat. Neurosci."},{"issue":"2","key":"20757_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1194\/jlr.M055624","volume":"56","author":"A Reis","year":"2015","unstructured":"Reis, A. et al. Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease. J. Lipid Res. 56(2), 413\u2013422. https:\/\/doi.org\/10.1194\/jlr.M055624 (2015) (Epub 2014 Nov 25).","journal-title":"J. Lipid Res."},{"issue":"422","key":"20757_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cca.2013.03.033","volume":"25","author":"YY Zhao","year":"2013","unstructured":"Zhao, Y. Y. Metabolomics in chronic kidney disease. Clin. Chim. Acta 25(422), 59\u201369. https:\/\/doi.org\/10.1016\/j.cca.2013.03.033 (2013) (Epub 2013 Apr 6).","journal-title":"Clin. Chim. Acta"},{"issue":"220","key":"20757_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cbi.2014.06.029","volume":"5","author":"YY Zhao","year":"2014","unstructured":"Zhao, Y. Y., Wu, S. P., Liu, S., Zhang, Y. & Lin, R. C. Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications. Chem. Biol. Interact. 5(220), 181\u2013192. https:\/\/doi.org\/10.1016\/j.cbi.2014.06.029 (2014) (Epub 2014 Jul 9).","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"20757_CR19","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/ki.2014.31","volume":"85","author":"C Wanner","year":"2014","unstructured":"Wanner, C., Tonelli, M., Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members. KDIGO Clinical Practice Guideline for Lipid Management in CKD: Summary of recommendation statements and clinical approach to the patient. Kidney Int. 85(6), 1303\u20131309. https:\/\/doi.org\/10.1038\/ki.2014.31 (2014) (Epub 2014 Feb 19).","journal-title":"Kidney Int."},{"issue":"1","key":"20757_CR20","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1021\/acs.analchem.8b03409","volume":"91","author":"MI Alcoriza-Balaguer","year":"2019","unstructured":"Alcoriza-Balaguer, M. I. et al. LipidMS: An R package for lipid annotation in untargeted liquid chromatography-data independent acquisition-mass spectrometry lipidomics. Anal. Chem. 91(1), 836\u2013845. https:\/\/doi.org\/10.1021\/acs.analchem.8b03409 (2019) (Epub 2018 Dec 13).","journal-title":"Anal. Chem."},{"issue":"9753","key":"20757_CR21","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"C Baigent","year":"2010","unstructured":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration et al. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376(9753), 1670\u20131681. https:\/\/doi.org\/10.1016\/S0140-6736(10)61350-5 (2010) (Epub 2010 Nov 8).","journal-title":"Lancet"},{"issue":"5","key":"20757_CR22","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.ahj.2010.08.012","volume":"160","author":"Sharp Collaborative Group","year":"2010","unstructured":"Sharp Collaborative Group. Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. Am. Heart J. 160(5), 785-794.e10. https:\/\/doi.org\/10.1016\/j.ahj.2010.08.012 (2010) (Epub 2010 Sep 18).","journal-title":"Am. Heart J."},{"issue":"1","key":"20757_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1468-6708-6-9","volume":"6","author":"B Fellstr\u00f6m","year":"2005","unstructured":"Fellstr\u00f6m, B. et al. Effect of rosuvastatin on outcomes in chronic haemodialysis patients\u2014design and rationale of the AURORA study. Curr. Controlled Trials Cardiovasc. Med. 6(1), 9. https:\/\/doi.org\/10.1186\/1468-6708-6-9 (2005).","journal-title":"Curr. Controlled Trials Cardiovasc. Med."},{"issue":"4","key":"20757_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000080241","volume":"27","author":"C Wanner","year":"2004","unstructured":"Wanner, C. et al. Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): Demographic and baseline characteristics. Kidney Blood Press. Res. 27(4), 259\u2013266. https:\/\/doi.org\/10.1159\/000080241 (2004) (Epub 2004 Aug 16).","journal-title":"Kidney Blood Press. Res."},{"issue":"4","key":"20757_CR25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1001\/jama.291.4.451","volume":"291","author":"Y Liu","year":"2004","unstructured":"Liu, Y. et al. Association between cholesterol level and mortality in dialysis patients: Role of inflammation and malnutrition. JAMA 291(4), 451\u2013459. https:\/\/doi.org\/10.1001\/jama.291.4.451 (2004).","journal-title":"JAMA"},{"key":"20757_CR26","unstructured":"The Effect of Dapagliflozin on Ultrafiltration Among Peritoneal Dialysis Patients, ClinicalTrials.gov Identifier: NCT04923295. An-Najah National University, June 2021."},{"key":"20757_CR27","unstructured":"Reduction of Peritoneal Glucose Uptake With Use of SGLT2 in Humans Undergoing Peritoneal Dialysis Treatment (PRESERVE), ClinicalTrials.gov Identifier: NCT05250752. Holbaek Sygehus, Feb 2022."},{"key":"20757_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.5551\/jat.12849","volume":"20","author":"WF Keane","year":"2013","unstructured":"Keane, W. F., Tomassini, J. E. & Neff, D. R. Lipid abnormalities in patients with chronic kidney disease: Implications for the pathophysiology of atherosclerosis. J. Atheroscler. Thromb. 20, 123\u2013213 (2013).","journal-title":"J. Atheroscler. Thromb."},{"key":"20757_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000190318","volume":"77","author":"Z Varga","year":"1997","unstructured":"Varga, Z., Karpati, I. & Paragh, G. Relative abundance of some free fatty acids in plasma of uremic patients: Relationship between fatty acids, lipid parameters, and disease. Nephron 77, 417\u2013421 (1997).","journal-title":"Nephron"},{"issue":"1","key":"20757_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000351764","volume":"38","author":"AN Friedman","year":"2013","unstructured":"Friedman, A. N. et al. Fatty acids and other risk factors for sudden cardiac death in patients starting hemodialysis. Am. J. Nephrol. 38(1), 12\u201318. https:\/\/doi.org\/10.1159\/000351764 (2013) (Epub 2013 Jun 25).","journal-title":"Am. J. Nephrol."},{"issue":"2","key":"20757_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0952-3278(02)00261-2","volume":"68","author":"M Miyazaki","year":"2003","unstructured":"Miyazaki, M. & Ntambi, J. M. Role of stearoyl-coenzyme A desaturase in lipid metabolism. Prostaglandins Leukotrienes Essential Fatty Acids 68(2), 113\u2013121 (2003).","journal-title":"Prostaglandins Leukotrienes Essential Fatty Acids"},{"issue":"9","key":"20757_CR32","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/S0022-2275(20)33401-5","volume":"40","author":"JM Ntambi","year":"1999","unstructured":"Ntambi, J. M. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J. Lipid Res. 40(9), 1549\u20131558 (1999).","journal-title":"J. Lipid Res."},{"issue":"17","key":"20757_CR33","doi-asserted-by":"publisher","first-page":"11482","DOI":"10.1073\/pnas.132384699","volume":"99","author":"JM Ntambi","year":"2002","unstructured":"Ntambi, J. M. et al. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc. Natl. Acad. Sci. USA 99(17), 11482\u201311486. https:\/\/doi.org\/10.1073\/pnas.132384699 (2002) (Epub 2002 Aug 12).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"20757_CR34","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1161\/atvbaha.107.160150","volume":"28","author":"R Mar-Heyming","year":"2008","unstructured":"Mar-Heyming, R. et al. Association of stearoyl-CoA desaturase 1 activity with familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 28(6), 1193\u20131199. https:\/\/doi.org\/10.1161\/atvbaha.107.160150 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"20757_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/ATVBAHA.109.198036","volume":"30","author":"JM Brown","year":"2010","unstructured":"Brown, J. M. et al. Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 30(1), 24\u201330 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"20757_CR36","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1194\/jlr.m200189-jlr200","volume":"43","author":"AD Attie","year":"2002","unstructured":"Attie, A. D. et al. Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J. Lipid Res. 43(11), 1899\u20131907. https:\/\/doi.org\/10.1194\/jlr.m200189-jlr200 (2002).","journal-title":"J. Lipid Res."},{"issue":"36","key":"20757_CR37","doi-asserted-by":"publisher","first-page":"25189","DOI":"10.1074\/jbc.274.36.25189","volume":"274","author":"TM McIntyre","year":"1999","unstructured":"McIntyre, T. M., Zimmerman, G. A. & Prescott, S. M. Biologically active oxidized phospholipids. J. Biol. Chem. 274(36), 25189\u201325192. https:\/\/doi.org\/10.1074\/jbc.274.36.25189 (1999).","journal-title":"J. Biol. Chem."},{"key":"20757_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3346\/jkms.2013.28.2.268","volume":"28","author":"Y-K Lee","year":"2013","unstructured":"Lee, Y.-K. et al. Lysophosphatidylcholine, oxidized low-density lipoprotein and cardiovascular disease in Korean hemodialysis patients: Analysis at 5 years of follow-up. J. Korean Med. Sci. 28, 268\u2013273 (2013).","journal-title":"J. Korean Med. Sci."},{"issue":"21","key":"20757_CR39","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.116.023233","volume":"134","author":"ZH Alshehry","year":"2016","unstructured":"Alshehry, Z. H. et al. Plasma lipidomic profiles improve on traditional risk factors for the prediction of cardiovascular events in type 2 diabetes mellitus. Circulation 134(21), 1637\u20131650. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.023233 (2016) (Epub 2016 Oct 18).","journal-title":"Circulation"},{"key":"20757_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1743-7075-3-5","volume":"3","author":"A Schlitt","year":"2006","unstructured":"Schlitt, A. et al. Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease. Nutr. Metab. (Lond.) 3, 5 (2006).","journal-title":"Nutr. Metab. (Lond.)"},{"issue":"39","key":"20757_CR41","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano, A. L. et al. 2016 ESC\/EAS guidelines for the management of dyslipidaemias. Eur. Heart J. 37(39), 2999\u20133058. https:\/\/doi.org\/10.1093\/eurheartj\/ehw272 (2016) (Epub 2016 Aug 27).","journal-title":"Eur. Heart J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20757-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20757-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20757-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T09:32:00Z","timestamp":1664530320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20757-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["20757"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-20757-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"assertion":[{"value":"9 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16394"}}